Journal of Veterinary Internal Medicine最新文献

{"title":"Effect of heart failure on dipeptidyl peptidase IV activity in plasma of dogs.","authors":"N Gomez,&nbsp;V Matheeussen,&nbsp;C Damoiseaux,&nbsp;A Tamborini,&nbsp;A C Merveille,&nbsp;P Jespers,&nbsp;C Michaux,&nbsp;C Clercx,&nbsp;I De Meester,&nbsp;K Mc Entee","doi":"10.1111/j.1939-1676.2012.00942.x","DOIUrl":"https://doi.org/10.1111/j.1939-1676.2012.00942.x","url":null,"abstract":"<p><strong>Background: </strong>In congestive heart failure (HF), plasma B-type natriuretic peptide (BNP) seems devoid of biological effectiveness. BNP(1-32) could be truncated into BNP(3-32) by dipeptidyl peptidase IV (DPP4), and BNP(3-32) has reduced biological activities.</p><p><strong>Hypothesis: </strong>Increased DPP4 activity is associated with pathophysiology of HF.</p><p><strong>Animals: </strong>One hundred twenty-eight client-owned dogs and 9 experimental Beagles from the Clinical Veterinary Unit of the University of Liège.</p><p><strong>Methods: </strong>We prospectively measured plasma DPP4 activity in 5 groups of dogs: normal growing dogs (n = 21), normal adult dogs (n = 60), healthy Beagle (n = 9), dogs with myxomatous mitral valve disease (n = 35), and dogs with dilated cardiomyopathy (n = 12). The final diagnosis and the severity of HF were determined by Doppler echocardiography. Plasma DPP4 activity was measured kinetically by a fluorimetric method.</p><p><strong>Results: </strong>In growing dogs, DPP4 activity was higher than in adults (P < .001) and inversely correlated with age (r = -0.57, P < .01). In adults, DPP4 activity increased linearly with body weight (r = 0.39, P < .01), but there was no influence of age or sex. No effect of the circadian rhythm was noted. DPP4 activity was significantly higher in HF ISACHC I (16.3 ± 1.14 U/L) compared with healthy adults (12.4 ± 0.65 U/L, P < .05) and HF ISACHC III (11.0 ± 1.50 U/L, P < .05). Mean DPP4 activity in ISACHC II was 15.1 ± 1.4 U/L.</p><p><strong>Conclusion and clinical importance: </strong>We did not find evidence that plasma DPP4 activity is responsible for the \"BNP resistance\" in overt congestive HF, but it may be implicated in early stages.</p>","PeriodicalId":17462,"journal":{"name":"Journal of Veterinary Internal Medicine","volume":"26 4","pages":"929-34"},"PeriodicalIF":2.6,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1939-1676.2012.00942.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30625741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cardiac troponin I in calves with congenital heart disease.","authors":"K Suzuki,&nbsp;E Uchida,&nbsp;K E Schober,&nbsp;A Niehaus,&nbsp;M D Rings,&nbsp;J Lakritz","doi":"10.1111/j.1939-1676.2012.00953.x","DOIUrl":"https://doi.org/10.1111/j.1939-1676.2012.00953.x","url":null,"abstract":"<p><strong>Background: </strong>The association between plasma cardiac troponin I (cTnI) and the magnitude of cardiac enlargement in calves with congenital heart disease (CHD) are not well defined.</p><p><strong>Objective: </strong>To investigate the relationship between plasma cTnI concentrations and cardiac size in healthy calves and calves with CHD.</p><p><strong>Animals: </strong>A total of 19 healthy calves (control) and 12 Holstein calves with CHD (patent ductus arteriosus, ventricular septal defect, tetralogy of Fallot or double outlet right ventricle).</p><p><strong>Methods: </strong>Case control study. All animals underwent a comprehensive transthoracic echocardiographic study to document cardiac health or presence of CHD. The vertebral heart score (VHS) was determined in each animal using right lateral survey radiographic images. Blood samples were collected via jugular venipuncture and plasma cTnI concentration and creatine kinase (CK) activity were determined by a 3rd generation immunoassay and an automatic biochemical analyzer, respectively. Groups were compared using Mann-Whitney U-test and receiver-operating characteristics (ROC) curve analysis.</p><p><strong>Results: </strong>Calves with CHD had significantly larger VHS values and higher plasma cTnI concentrations (P < .001) compared to control. Creatine kinase activity was not different between the control and CHD groups of calves. Diagnostic cutoffs of VHS and plasma cTnI for discrimination of groups were 8.9 vertebrae and 0.035 ng/mL, respectively. The cTnI concentration in plasma was significantly correlated with VHS (r (2) =0.512, P < .001).</p><p><strong>Conclusion and clinical relevance: </strong>Our results suggest that determination of plasma cTnI concentrations in calves with clinical signs compatible with CHD might prove useful as a guide to quantify cardiac remodeling associated with increased cardiac size.</p>","PeriodicalId":17462,"journal":{"name":"Journal of Veterinary Internal Medicine","volume":"26 4","pages":"1056-60"},"PeriodicalIF":2.6,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1939-1676.2012.00953.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30680517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Seasonal changes in the combined glucose-insulin tolerance test in normal aged horses.","authors":"R A Funk,&nbsp;A A Wooldridge,&nbsp;A J Stewart,&nbsp;E N Behrend,&nbsp;R J Kemppainen,&nbsp;Q Zhong,&nbsp;A K Johnson","doi":"10.1111/j.1939-1676.2012.00939.x","DOIUrl":"https://doi.org/10.1111/j.1939-1676.2012.00939.x","url":null,"abstract":"<p><strong>Background: </strong>Equine metabolic syndrome (EMS) is an increasingly recognized problem in adult horses. Affected horses are often obese and predisposed to the development of laminitis, especially in the spring and summer months. In addition, in the summer and fall months, increases in endogenous insulin concentrations, a marker of EMS, have been reported.</p><p><strong>Hypothesis/objectives: </strong>The purpose of this study was to evaluate seasonal changes in results of the combined glucose-insulin tolerance test (CGIT), a diagnostic test for EMS.</p><p><strong>Animals: </strong>Nine healthy, aged horses with no history of laminitis and no clinical signs of EMS.</p><p><strong>Methods: </strong>Horses were given dextrose (150 mg/kg) and insulin (0.1 U/kg) IV. Plasma glucose concentrations were measured at 0, 1, 5, 15, 30, 45, 60, 75, 90, and 150 minutes and serum insulin concentrations at 0, 5, and 75 minutes. Testing was performed in February, May, June, August, September, and November. Mean glucose concentrations, characteristics of the curve, and insulin concentrations during the CGIT were compared across months using repeated measures ANOVA (P < .05).</p><p><strong>Results: </strong>No CGIT parameters indicated insulin resistance, but mean area under the curve for glucose concentrations was significantly lower in August and November compared to February and in November compared to June, indicating increased insulin-mediated glucose clearance. Glucose nadir was significantly lower in November compared to that in February.</p><p><strong>Conclusions and clinical importance: </strong>No clinically relevant differences were seen in the results of the CGIT, suggesting that season minimally affects results of this test in normal aged horses in the southeastern United States.</p>","PeriodicalId":17462,"journal":{"name":"Journal of Veterinary Internal Medicine","volume":"26 4","pages":"1035-41"},"PeriodicalIF":2.6,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1939-1676.2012.00939.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30624986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The prevalence of leptospiral antibodies in free roaming cats in Worcester County, Massachusetts.","authors":"J E Markovich,&nbsp;L Ross,&nbsp;E McCobb","doi":"10.1111/j.1939-1676.2012.00900.x","DOIUrl":"https://doi.org/10.1111/j.1939-1676.2012.00900.x","url":null,"abstract":"<p><strong>Background: </strong>Serosurveys of cats for exposure to or infection with leptospires have been published from other geographic areas, but none for cats in the United States in the past 4 decades.</p><p><strong>Hypothesis/objectives: </strong>The purpose of this pilot study was to determine the prevalence of leptospiral antibodies in a population of free roaming cats in Worcester County, (central) Massachusetts.</p><p><strong>Animals: </strong>Sixty-three free roaming cats presenting to a trap-neuter-return (TNR) program.</p><p><strong>Methods: </strong>Prospective study. Serum was collected from 63 free roaming cats presented to a university associated TNR. Microagglutination titers to Leptospira interrogans serovars Autumnalis, Hardjo, Bratislava, Icterohaemorrhagiae, Canicola, Pomona, and L kirshneri Grippotyphosa were determined.</p><p><strong>Results: </strong>A total of 3 of 63 cats (4.8%) had a titer of 1 : 100 or greater to one or more serovars, with Autumnalis being the most common. None of the cats were seropositive to Hardjo, Grippotyphosa, or Canicola.</p><p><strong>Conclusions and clinical importance: </strong>These results are consistent with previously published seroprevalence rates in feral cats. Additional studies are required to determine the role of leptosporosis in clinical disease in the domestic cat.</p>","PeriodicalId":17462,"journal":{"name":"Journal of Veterinary Internal Medicine","volume":"26 3","pages":"688-9"},"PeriodicalIF":2.6,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1939-1676.2012.00900.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30505808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Importance of the effective strong ion difference of an intravenous solution in the treatment of diarrheic calves with naturally acquired acidemia and strong ion (metabolic) acidosis.","authors":"K R Müller,&nbsp;A Gentile,&nbsp;W Klee,&nbsp;P D Constable","doi":"10.1111/j.1939-1676.2012.00917.x","DOIUrl":"https://doi.org/10.1111/j.1939-1676.2012.00917.x","url":null,"abstract":"<p><strong>Background: </strong>The effect of sodium bicarbonate on acid-base balance in metabolic acidosis is interpreted differently by Henderson-Hasselbalch and strong ion acid-base approaches. Application of the traditional bicarbonate-centric approach indicates that bicarbonate administration corrects the metabolic acidosis by buffering hydrogen ions, whereas strong ion difference theory indicates that the co-administration of the strong cation sodium with a volatile buffer (bicarbonate) corrects the strong ion acidosis by increasing the strong ion difference (SID) in plasma.</p><p><strong>Objective: </strong>To investigate the relative importance of the effective SID of IV solutions in correcting acidemia in calves with diarrhea.</p><p><strong>Animals: </strong>Twenty-two Holstein-Friesian calves (4-21 days old) with naturally acquired diarrhea and strong ion (metabolic) acidosis.</p><p><strong>Methods: </strong>Calves were randomly assigned to IV treatment with a solution of sodium bicarbonate (1.4%) or sodium gluconate (3.26%). Fluids were administered over 4 hours and the effect on acid-base balance was determined.</p><p><strong>Results: </strong>Calves suffered from acidemia owing to moderate to strong ion acidosis arising from hyponatremia and hyper-D-lactatemia. Sodium bicarbonate infusion was effective in correcting the strong ion acidosis. In contrast, sodium gluconate infusion did not change blood pH, presumably because the strong anion gluconate was minimally metabolized.</p><p><strong>Conclusions: </strong>A solution containing a high effective SID (sodium bicarbonate) is much more effective in alkalinizing diarrheic calves with strong ion acidosis than a solution with a low effective SID (sodium gluconate). Sodium gluconate is ineffective in correcting acidemia, which can be explained using traditional acid-base theory but requires a new parameter, effective SID, to be understood using the strong ion approach.</p>","PeriodicalId":17462,"journal":{"name":"Journal of Veterinary Internal Medicine","volume":"26 3","pages":"674-83"},"PeriodicalIF":2.6,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1939-1676.2012.00917.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30561128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Qualitative and quantitative characteristics of the electroencephalogram in normal horses after sedation.","authors":"D C Williams,&nbsp;M Aleman,&nbsp;B Tharp,&nbsp;D J Fletcher,&nbsp;P H Kass,&nbsp;E P Steffey,&nbsp;R A LeCouteur,&nbsp;T A Holliday","doi":"10.1111/j.1939-1676.2012.00921.x","DOIUrl":"https://doi.org/10.1111/j.1939-1676.2012.00921.x","url":null,"abstract":"<p><strong>Background: </strong>The administration of certain sedatives has been shown to promote sleep in humans. Related agents induce sleep-like behavior when administered to horses. Interpretation of electroencephalograms (EEGs) obtained from sedated horses should take into account background activity, presence of sleep-related EEG events, and the animal's behavior.</p><p><strong>Hypothesis: </strong>Sedatives induce states of vigilance that are indistinguishable on EEGs from those that occur naturally.</p><p><strong>Animals: </strong>Six healthy horses.</p><p><strong>Methods: </strong>Digital EEG with video was recorded after administration of 1 of 4 sedatives (acepromazine, butorphanol, xylazine, or detomidine). Serum drug concentrations were measured. Recordings were reviewed, states were identified, and representative EEG samples were analysed. These data were compared with data previously obtained during a study of natural sleep.</p><p><strong>Results: </strong>Butorphanol was associated with brief episodes resembling slow wave sleep in 1 horse. Acepromazine led to SWS in 3 horses, including 1 that also exhibited rapid eye movement sleep. Periods of SWS were observed in all horses afer xylazine or detomidine administration. Normal sleep-related EEG events and heart block, occurred in association with SWS regardless of which sedative was used. Spectral data varied primarily by state, but some differences were observed between sedative and natural data.</p><p><strong>Conclusions and clinical importance: </strong>Qualitatively, EEG findings appeared identical whether sedation-induced or naturally occurring. The startle response and heart block associated with some sedatives may be related to sleep. Alpha(2) agonists can be used to obtain high quality EEGs in horses, but acepromazine does not promote a relaxed state in all animals.</p>","PeriodicalId":17462,"journal":{"name":"Journal of Veterinary Internal Medicine","volume":"26 3","pages":"645-53"},"PeriodicalIF":2.6,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1939-1676.2012.00921.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30563719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A randomized trial investigating the efficacy and safety of water soluble micellar paclitaxel (Paccal Vet) for treatment of nonresectable grade 2 or 3 mast cell tumors in dogs.","authors":"D M Vail, H von Euler, A W Rusk, L Barber, C Clifford, R Elmslie, L Fulton, J Hirschberger, M Klein, C London, M Martano, E A McNiel, J S Morris, N Northrup, B Phillips, G Polton, G Post, M Rosenberg, D Ruslander, A Sahora, S Siegel, D Thamm, S Westberg, J Winter, C Khanna","doi":"10.1111/j.1939-1676.2012.00897.x","DOIUrl":"10.1111/j.1939-1676.2012.00897.x","url":null,"abstract":"<p><strong>Background: </strong>Effective treatments for dogs with advanced stage mast cell tumors (MCT) remain a pressing need. A micellar formulation of paclitaxel (paclitaxel [micellar]) has shown promise in early-phase studies.</p><p><strong>Hypothesis/objectives: </strong>The objective was to demonstrate greater activity for paclitaxel (micellar) compared with lomustine. The null hypothesis was μ(p) = μ(L) (ie, proportion of responders for the paclitaxel [micellar] and lomustine groups, respectively).</p><p><strong>Animals: </strong>Two hundred and fifty-two dogs with advanced stage nonresectable grade 2 or 3 MCT.</p><p><strong>Methods: </strong>Prospective multicenter randomized double-blind positive-controlled clinical trial. The primary endpoint was confirmed overall response rate (CORR) at 14 weeks. A secondary endpoint, biologic observed response rate (BORR), also was calculated. Safety was assessed by the characterization and grading of adverse events (AE).</p><p><strong>Results: </strong>Overall CORR (7% versus 1%; P = .048) and BORR (23% versus 10%; P = .012) were greater for paclitaxel (micellar) compared with lomustine. Paclitaxel (micellar)-treated dogs were 6.5 times more likely to have a confirmed response and 3.1 times more likely to experience a biologic observed response. The majority of AE with paclitaxel (micellar) were transient and clinically manageable. Twenty-seven dogs (33%) receiving lomustine were discontinued because of hepatopathy compared with 3 dogs (2%) receiving paclitaxel (micellar) (P < .0001; odds ratio 26.7).</p><p><strong>Conclusions and clinical importance: </strong>Paclitaxel (micellar)'s activity and safety profile are superior to lomustine. The addition of an active and novel taxane to the veterinary armamentarium could fill a substantial need and, as its mechanism of action and AE profile do not overlap with currently available TKI, its availability could lead to effective combination protocols.</p>","PeriodicalId":17462,"journal":{"name":"Journal of Veterinary Internal Medicine","volume":"26 3","pages":"598-607"},"PeriodicalIF":2.6,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837094/pdf/nihms-462480.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30506096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparative potential therapeutic effect of sesame oil and peanut oil against acute monocrotaline (Crotalaria) poisoning in a rat model.","authors":"P Srinivasan,&nbsp;M-Y Liu","doi":"10.1111/j.1939-1676.2012.00909.x","DOIUrl":"https://doi.org/10.1111/j.1939-1676.2012.00909.x","url":null,"abstract":"<p><strong>Background: </strong>Many Crotalaria plant species contain hepatotoxic pyrrolizidine alkaloids (such as monocrotaline) that can cause acute and chronic poisoning in cattle and other animals.</p><p><strong>Hypothesis: </strong>Peanut oil, atropine sulfate, and antidiarrheal agents are used to treat acute monocrotaline poisoning. The effect of sesame on acute monocrotaline poisoning has never been investigated.</p><p><strong>Animals: </strong>Fifty male Sprague-Dawley rats were used for toxicity studies.</p><p><strong>Methods: </strong>Experiment 1: Group I, control. Groups II-IV were given monocrotaline (205.2 mg/kg) and euthanized 6, 12, and 24 hours later. Experiment 2: Group I, control. Group II monocrotaline alone (205.2 mg/kg). Groups III-VI were given monocrotaline (205.2 mg/kg) and 1 hour later, Groups III and IV were given sesame oil (1 and 2 mL/kg) and Groups V and VI were given peanut oil (1 and 2 mL/kg).</p><p><strong>Results: </strong>Monocrotaline significantly decreased (P < .05) serum amylase activity, but, over time, increased (P < .05) pancreatic and lung injury. AST and ALT activity and liver injury peaked at 24 hours. Sesame oil and peanut oil (P < .05) inhibited the changes in all tested parameters in acute monocrotaline poisoning. Although peanut oil inhibited acute monocrotaline poisoning, it induced steatosis, but sesame oil did not.</p><p><strong>Conclusion and clinical importance: </strong>We hypothesize that early pancreatic and lung injury and late liver injury contribute to acute monocrotaline poisoning and that sesame oil is more efficacious than peanut oil against acute monocrotaline poisoning in rats. However, additional studies are needed to confirm that these oils have the same effects in cattle and other animals.</p>","PeriodicalId":17462,"journal":{"name":"Journal of Veterinary Internal Medicine","volume":"26 3","pages":"491-9"},"PeriodicalIF":2.6,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1939-1676.2012.00909.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30524407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long-term follow-up of renal function in dogs after treatment for ACTH-dependent hyperadrenocorticism.","authors":"P M Y Smets,&nbsp;H P Lefebvre,&nbsp;B P Meij,&nbsp;S Croubels,&nbsp;E Meyer,&nbsp;I Van de Maele,&nbsp;S Daminet","doi":"10.1111/j.1939-1676.2012.00915.x","DOIUrl":"https://doi.org/10.1111/j.1939-1676.2012.00915.x","url":null,"abstract":"<p><strong>Background: </strong>Systemic hypertension and proteinuria are frequent complications in dogs with Cushing's syndrome and do not always resolve after treatment of hypercortisolism. Therefore, dogs with Cushing's syndrome may be at risk for renal dysfunction before and after treatment.</p><p><strong>Hypothesis/objectives: </strong>To assess renal function in dogs with ACTH-dependent hyperadrenocorticism (ADHAC) before and after treatment.</p><p><strong>Animals: </strong>A total of 19 dogs with ADHAC and 12 control dogs.</p><p><strong>Methods: </strong>Renal function was assessed before and at 1, 3, 6, and 12 months after treatment. Twelve dogs were treated with trilostane and 7 dogs by transsphenoidal hypophysectomy. Routine renal markers were measured and urinary albumin (uALB), immunoglobulin G (uIgG), and retinol-binding protein (uRBP) were assessed by ELISA. Urinary N-acetyl-β-D-glucosaminidase (uNAG) was determined colorimetrically. All urinary markers were indexed to urinary creatinine concentration (c). Plasma clearance of creatinine (Cl(creat)), exo-iohexol (Cl(exo)), and endo-iohexol (Cl(endo)) was used to measure glomerular filtration rate (GFR). Data were analyzed using a general linear model.</p><p><strong>Results: </strong>Serum creatinine and urea concentrations increased post-treatment, but remained within reference ranges. Plasma Cl(creat) and Cl(endo) were significantly lower post-treatment, whereas Cl(exo) was not different. Urinary protein-to-creatinine ratio (UPC), uALB/c, uIgG/c, and uRBP/c were decreased post-treatment, but at 12 months 5/13 dogs remained proteinuric. Urinary NAG/c did not change significantly.</p><p><strong>Conclusions and clinical importance: </strong>A decrease in GFR and persistent proteinuria post-treatment may warrant the clinician's attention. Future research including renal histopathology of dogs with persistent proteinuria or low GFR is needed to further assess renal outcome.</p>","PeriodicalId":17462,"journal":{"name":"Journal of Veterinary Internal Medicine","volume":"26 3","pages":"565-74"},"PeriodicalIF":2.6,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1939-1676.2012.00915.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30541353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sonoclot® evaluation of single- and multiple-dose subcutaneous unfractionated heparin therapy in healthy adult dogs.","authors":"D M Babski,&nbsp;B M Brainard,&nbsp;A G Ralph,&nbsp;J R Pittman,&nbsp;A Koenig","doi":"10.1111/j.1939-1676.2012.00907.x","DOIUrl":"https://doi.org/10.1111/j.1939-1676.2012.00907.x","url":null,"abstract":"<p><strong>Background: </strong>Heparin therapy is difficult to monitor due to variation in animal response. While laboratory measurements of activated partial thromboplasin time (aPTT) and Anti-Xa activity (AXA) accurately describe heparin effect, their availability is limited.</p><p><strong>Hypothesis: </strong>Sonoclot analysis would be as sensitive as AXA and aPTT to monitor effects of unfractionated heparin (UFH) in healthy adult dogs.</p><p><strong>Animals: </strong>Six adult mixed-breed dogs.</p><p><strong>Methods: </strong>A prospective study design was employed. On day 1, baseline samples were collected (CBC, PT, aPTT, and Sonoclot), and UFH (300 U/kg SC) was administered to 6 dogs following an IV loading dose of 50 U/kg. Sonoclot and aPTT were performed hourly for 12 hours. AXA was assayed at hours 3, 6, 9, and 12. UFH (300 U/kg q8 h SC) was administered at 12 hours, and subsequently (q8 h) for 2 additional days. On day 4, a final dose of UFH was administered, and a sampling protocol identical to day 1 was performed.</p><p><strong>Results: </strong>Sonoclot activated clotting time (ACT) and clot rate (CR) correlated with AXA (R = 0.69, R = 0.65, respectively, P < .001), although to a lesser degree than aPTT (R = 0.75, P < .001). Linear regression using ACT and CR as covariates indicated a stronger correlation with AXA (R = 0.73, P < .001). ACT values strongly correlated with aPTT (R = 0.87, P < .001).</p><p><strong>Conclusions and clinical importance: </strong>Administration of UFH to healthy dogs results in progressive changes in Sonoclot values. AXA was correlated with a combination of ACT and CR and with aPTT. Sonoclot may play a role in monitoring UFH therapy; however, prospective studies evaluating its utility in clinical cases are warranted.</p>","PeriodicalId":17462,"journal":{"name":"Journal of Veterinary Internal Medicine","volume":"26 3","pages":"631-8"},"PeriodicalIF":2.6,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1939-1676.2012.00907.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30518105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}